Bitancor, Alexander C.
HRN: 22-11-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/25/2022
11/13/2022
IV
4.5g
Q6
Penunonia; Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes